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Objective Objective assessments of sedentary behavior, physical activity (PA) and the associated 
energy expenditure (EE) using accelerometer-based wearable devices are ever expanding, given 
their importance in the global context of health maintenance. However, among these numerous 
devices, the different underlying algorithms and available output parameters make it difficult to 
determine their accuracy. Furthermore, the function and accuracy of those devices may significantly 
differ between the different wearing locations (i.e., wrist-worn, waist-worn or thigh-based), where 
the center of the body (hip or thigh) is the optimal recommendation. Thus, a thigh-based device that 
has the possibility to differentiate between sedentary behavior, PAs, and EE is required to optimize 
research in PA. This study aimed to determine the reliability and validity of a new accelerometer-
based analyzer (Fibion) with two-fold: First, to assess the reliability of the Fibion as compared to a 
designed repeated protocol and ActiGraph GT9X (one of the most widely used devices with favorable 
validity and reliability) in a laboratory re-test protocol; Second, to determine the validity of the 
Fibion in differentiating PAs and estimating EE throughout a simulated 12-hour free-living day. 
Methods Fibion (Fibion Inc, Jyväskylä, Finland) is a new 3-axial lightweight (20g, L•W•T = 
30•32•10mm) accelerometer-based device, which was designed to follow the orientation and 
movement of the thigh. Thus, it can be worn either on the thigh (FT) or in the front pocket of the 
trousers (FP). According to information provided by the manufacturer, it is able to detect no-wear 
time and differentiates between different types (sitting, long sitting, standing, walking, and cycling) 
and intensities (LPA, MVPA, and VPA) of PA and the associated EE through the use of proprietary 
algorithms. 
The study consisted of two parts: a reliability (n=18) and validity (n=19) test, respectively. All 37 
participants were young and healthy volunteers, who were normal weight (i.e., BMI < 25 kg/m2) and 
recreationally physically active. Exclusion criteria included acute and chronic diseases, which would 
prevent participants from prolonged sitting and/or standing or would interfere with the basic 
metabolic rate. All participants were informed about the study procedures and provided written 
informed consent prior to commencing with testing. The study was carried out in accordance with 
the Declaration of Helsinki and the local Ethical Committee (ML16027). 
Reliability was assessed by a designed 15-min protocol by repeating sitting, standing, and walking (a 
total of 90 min = 15 min *3 types * 2 repeats) using both Fibion (FT) and ActiGraph. Validity was 
assessed by a prolonged 12-h protocol which was designed as simulated free-living conditions with 
two criteria. Criterion 1: Direct observation of the 12-h continuous sequence of tasks with 
measurement logs, to determine the duration of different types (sitting, standing, walking, and 
cycling) and intensities (light [LPA], moderate-to-vigorous [MVPA], and vigorous [VPA])) of PA. 
Indirect calorimetry served as the criterion 2 for EE estimation. Pulmonary gas exchange of the 
participants was continuously measured throughout the 12-h guided sequence of tasks by a portable 
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breath-by-breath gas analyzer (Cosmed K4b2, Rome, Italy). During the entire 12-h protocol, two 
Fibion devices (worn both on the thigh (FT) and in the pocket (FP), respectively) and K4b2 were 
used simultaneously.  
Results Reliability. Fibion located on the thigh (FT) (ICCs: 0.687-0.806) provided similar reliability 
for EE estimation as the Actigraph (ICCs: 0.661-0.806). However, the measurement error for FT 
indicated an underestimation of activity times by 5.1 ± 1.2%, 3.8 ± 0.3% and 14.9 ± 2.6% during 
sitting, walking, and standing, respectively. Furthermore, low correlations were observed between 
subsequent measurements with both devices (ICCs 0.189-0.459), especially in low intensities 
(sitting). Validity. During the prolonged 12-h simulated real-life conditions, FT but not FP showed a 
moderate agreement with the direct observation in assessing the duration of sitting, long sitting, LPA, 
MVPA, and VPA (p>0.05, ICCs: 0.071-0.537), but the low correlations between Fibion and the criteria 
(ICCs FT: 0.016-0.638; FP: -0.046 to 0.650) indicate that the measurement error is random. Similarly, 
FT but not FP showed a moderate agreement with the K4b2 for EE estimation of standing, LPA, 
MVPA, and VPA (p>0.05, ICCs: 0.673-0.894).  
Conclusions In summary, the location of the accelerometer is essential for accurately assessing PA 
and EE. FT appeared to detect sitting and walking with a small measurement error, similar to that of 
the Actigraph. Considering the random error observed in our study, further studies with larger 
populations are needed to confirm the practical usability of Fibion (FT) for estimating different types 
and intensities of PA. 
 
